52 followers
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial. https://t.co/dYnlZzDXrV
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial. https://t.co/dYnlZzDXrV
@_johnedwards @BTOGORG My thoughts exactly as soon as I read the Streamline L paper 🤔 https://t.co/2OUgtNmNEk
RT @profstuartaylor: WB-MRI a viable first line staging test in colon and lung cancer. Read the results of the Streamline trials in Lancet…
@TheCIMR